ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹922 Cr | ₹819 Cr | ₹666 Cr | ₹560 Cr | ₹450 Cr |
What is the latest Revenue of ORCHID PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹922 Cr |
| Mar2024 | ₹819 Cr |
| Mar2023 | ₹666 Cr |
| Mar2022 | ₹560 Cr |
| Mar2021 | ₹450 Cr |
How is Revenue of ORCHID PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹922 Cr | 12.52 | |
| Mar2024 | ₹819 Cr | 23.05 | |
| Mar2023 | ₹666 Cr | 19.00 | |
| Mar2022 | ₹560 Cr | 24.33 | |
| Mar2021 | ₹450 Cr | - | |
Compare Revenue of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹3,388.8 Cr | -1.1% | -4.2% | -46.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -1.1% |
-4.2% |
-46.2% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses